# The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-combination-of-sirolimus-and-rosiglitazone-produces-a-renoprotective-effect/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Maria Flaquer,Núria Lloberas,Marcella Franquesa,Joan Torrás,August Vidal,José Luís Rosa,I. Herrero,Josep M. Grinyó,Josep M. Cruzado |
| Citations | 28 |
| DOI | 10.1016/j.lfs.2010.06.004 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2038810715 |
| PMID | 20600147 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Maria Flaquer](https://scholariq.org/researchers/maria-flaquer/)

## Paper journal

- [Life Sciences](https://scholariq.org/journals/life-sciences/)

## Paper primary topic

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Paper topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.